ghk-cu subcutaneous dosage recommendations and Protocol: A Medical Provider's Guide to the 30-Day Cycle GHK-Cu Peptide Therapy: The Definitive

GHK naturally occurs in human plasma at approximately 200 ng/mL in young adults, declining significantly with age (PMID 29986520)

Wnt signaling in the nervous system and in Alzheimers disease

Loss of RNF43 function contributes to gastric carcinogenesis by impairing DNA damage response

Fibulins: multiple roles in matrix structures and tissue functions

Clinical Relevance: These findings explain GHK-Cu's accelerated wound closure observed in clinical settings and its interest as a therapeutic candidate for chronic wounds, post-surgical recovery, and tissue regeneration applications

Storage guidance from vendors follows standard peptide practices: store lyophilized Epithalon in a cool, dry place away from light